Neoplasm Treatment Market Share

North American Market Forecast   

The North American neoplasm treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the rising cases of cancer in the region. According to the US National Cancer Institute, an estimated of 1,806,590 new cases of cancer were diagnosed in the United States in 2020. Moreover, the presence of major research institutes in the region, combined with high healthcare expenditure, is estimated to boost the market growth. In addition, there has been a higher awareness related to the advanced technologies for cancer diagnostics and treatment in terms of chemotherapy, radiation, and others that is further anticipated to boost the market’s growth in the region.

Europe Market Forecast

The European neoplasm treatment market, amongst the market in all the other regions, is also projected to have significant growth during the forecast period. The growth of the market can be attributed majorly to the surging emphasis on neoplasm treatment, followed by rising prevalence of malignant cancers in the countries such as the United Kingdom. Furthermore, the rising clinical trials, and development of drugs for the treatment is further predicted to boost the growth of the market in the region. In addition, the increasing approval of the drug and its treatment by the FDA is expected to contribute to the factors that are supporting the market’s growth in the region.

APAC Market Statistics

The Asia Pacific neoplasm treatment market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growing geriatric population, and increasing population percentage are the major factors that are anticipated to boost the growth of the neoplasm treatment market in the region over the forecast period. Furthermore, improving healthcare facilities and policies are further predicted to increase the market’s growth in the Asia Pacific region.